Gene · 6891
Papers2,915
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 2,915
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenetic therapy to enhance therapeutic effects of PD-1 inhibition in therapy-resistant melanoma. | Melanoma Res | 2022 | 34753889 | PubTator, text mining | PubMed |
| Dysregulated lncRNA and mRNA may promote the progression of ischemic stroke via immune and inflammatory pathways: results from RNA sequencing and bioinformatics analysis. | Genes Genomics | 2022 | 34699043 | PubTator, text mining | PubMed |
| Viral Status Predicts the Patterns of Genome Methylation and Decitabine Response in Merkel Cell Carcinoma. | J Invest Dermatol | 2022 | 34474081 | PubTator, text mining | PubMed |
| Prolonged estrogen deprivation triggers a broad immunosuppressive phenotype in breast cancer cells. | Mol Oncol | 2022 | 34392603 | PubTator, text mining | PubMed |
| Maturation signatures of conventional dendritic cell subtypes in COVID-19 suggest direct viral sensing. | Eur J Immunol | 2022 | 34333764 | PubTator, text mining | PubMed |
| Rapid Regulation of Glutamate Transport: Where Do We Go from Here? | Neurochem Res | 2022 | 33893911 | PubTator, text mining | PubMed |
| Therapeutic anti-glioma effect of the combined action of PCSK inhibitor with the anti-tumoral factors secreted by Poly (I:C)-stimulated macrophages. | Cancer Gene Ther | 2022 | 33402730 | PubTator, text mining | PubMed |
| Designing of RNA aptamer against DNA binding domain of the glucocorticoid receptor: A response element-based in-silico approach. | J Biomol Struct Dyn | 2022 | 32964813 | PubTator, text mining | PubMed |
| The (re)discovery of tumor-intrinsic determinants of immune sensitivity by functional genetic screens. | Immunooncol Technol | 2021 | 35756970 | PubTator, text mining | PubMed |
| ABCA1 is associated with the development of acquired chemotherapy resistance and predicts poor ovarian cancer outcome. | Cancer Drug Resist | 2021 | 35582032 | PubTator, text mining | PubMed |
| Identification of Potential Pleiotropic Genes for Immune and Skeletal Diseases Using Multivariate MetaCCA Analysis. | Curr Genomics | 2021 | 35386192 | PubTator, text mining | PubMed |
| Low Expression of PLAT in Breast Cancer Infers Poor Prognosis and High Immune Infiltrating Level. | Int J Gen Med | 2021 | 35221711 | PubTator, text mining | PubMed |
| Exploration of Potential Integrated Models of N6-Methyladenosine Immunity in Systemic Lupus Erythematosus by Bioinformatic Analyses. | Front Immunol | 2021 | 35197962 | PubTator, text mining | PubMed |
| Autoimmune Pemphigus: Latest Advances and Emerging Therapies. | Front Mol Biosci | 2021 | 35187073 | PubTator, text mining | PubMed |
| Hyaluronic Acid Correlates With Bone Metastasis and Predicts Poor Prognosis in Small-Cell Lung Cancer Patients. | Front Endocrinol (Lausanne) | 2021 | 35154001 | PubTator, text mining | PubMed |
| Swine Enteric Coronaviruses (PEDV, TGEV, and PDCoV) Induce Divergent Interferon-Stimulated Gene Responses and Antigen Presentation in Porcine Intestinal Enteroids. | Front Immunol | 2021 | 35126380 | PubTator, text mining | PubMed |
| The Primary Immunodeficiency Database in Japan. | Front Immunol | 2021 | 35082792 | PubTator, text mining | PubMed |
| Novel Immune-Related Genetic Expression for Primary Sjögren's Syndrome. | Front Med (Lausanne) | 2021 | 35047519 | PubTator, text mining | PubMed |
| Advancement in Cancer Stem Cell Biology and Precision Medicine-Review Article Head and Neck Cancer Stem Cell Plasticity and the Tumor Microenvironment. | Front Cell Dev Biol | 2021 | 35047489 | PubTator, text mining | PubMed |
| Advances in Design Strategies of Multiplex Electrochemical Aptasensors. | Sensors (Basel) | 2021 | 35009703 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6891/papers?page=31